Laparoscopic Power Morcellator Uterine Surgery Lawsuits

Were you diagnosed with cancer after going through a surgery designed to remove uterine fibroids or the uterus itself?  If so, then you may qualify to file a lawsuit against the makers of the device used during the operation.

At the center of an ongoing controversy is the laparoscopic power morcellator, a device commonly used to provide a minimally invasive means of performing a hysterectomy (removal of the uterus) or a myomectomy (removal of uterine fibroids).  The device, which is used in approximately 50,000 operations each year in the United States, has been tied to an increased risk of cancerous tissue being distributed throughout the patient’s body, leaving that individual at a heightened risk of serious cancer.

Levy Baldante is currently providing free consultations to all those women who believe their cancer is the result of a procedure using the device, as well as to those families who lost loved ones to the same.  Our Pennsylvania and New Jersey medical device lawyers are reviewing the current situation and helping affected persons explore their litigation options.

A Brief History

The controversy picked up steam in April 2014, when the Food and Drug Administration released a scathing summary of the risks of laparoscopic power morcellation.  In posting their findings, the FDA noted the alarming finding that 1 in every 350 persons who undergo one of the aforementioned procedures may unknowingly suffer from a uterine sarcoma, a type of cancer with serious longterm health implications.

What makes the operation so dangerous is the way in which the device operates.  The morcellator allows a surgeon to split uterine tissue into smaller pieces, minimizing the cut that would otherwise be necessary in order to access the affected area.  Unfortunately, this process may allow the cancerous tissue to make its way to both the pelvis and the abdomen.

The chances for recovery are reduced dramatically when this happens.  While the sarcoma may have been contained before, morcellation essentially allows the cancer to escape into other portions of the body.

In April, the FDA called for new labeling intended to reflect the risks of the operation and discouraged doctors from using morcellation as a treatment for hysterectomies and myomectomies, even going so far as to strongly warn doctors never to use such a treatment if they know the patient could potentially suffer from uterine cancer.

An Ongoing Matter

Shortly after the FDA came out with their findings, Johnson & Johnson announced they would no longer be producing the items until more information was made known.  For many health and safety advocates, even this doesn’t go far enough.  They want to see an immediate recall of these products so that no one else will be put at risk by the devices.

The week of July 7 will find the FDA convening a panel of authorities to advise the agency on the best course of future action.  Among the options on the table are a product ban or more selective usage of power morcellator devices.

You Have Rights As A Patient

If you were one of the many women whose undiagnosed cancer spread to other parts of the body after going through a myomectomy or a hysterectomy, call Levy Baldante to learn more about your options.

Our attorneys are well-versed in matters of medical device liability, and we are offering our services to all those who were misled and are now dealing with serious and potentially life-threatening complications resulting from a laparoscopic power morcellation procedure.

Levy Baldante is standing by to offer free consultations to those who believe they may have a case.  We invite you to come to us with any questions you may have so that you get a better idea of the current situation.  You are under no obligation to hire us at the end of that consultation; we simply want you to be well-informed so that you have the best chance at receiving proper compensation for all that you’ve been through.

Contact the defective power morcellator lawyers of Levy Baldante today to get justice for your cause.

SOURCES:

http://www.fda.gov/newsEvents/Newsroom/PressAnnouncements/ucm393689.htm

http://www.medscape.com/viewarticle/824371

http://online.wsj.com/articles/showdown-for-surgical-tool-1402958775

http://finance.yahoo.com/news/fda-reviewers-assess-uterine-surgical-140430732.html